Insurance, Medicare & Medicaid

The Evidence-Informed State Health Policy Institute (ESHPI) developed a COVID-19-related research agenda exploring how Medicaid can examine the long-term impact on beneficiaries and the program.

With the recent expiration of the federal eviction moratorium and the heightened focus on social determinants of health during the COVID-19 pandemic, this new cross-state analysis of permanent supportive housing programs is timelier than ever.

With funding from the National Institutes on Drug Abuse (NIDA), Medicaid Outcomes Distributed Research Network (MODRN) members and AcademyHealth conducted key informant interviews with nine states to describe the roles that Medicaid programs have taken to address the opioid epidemic and their policy and operational decisions.

As lead clinicians for their states with responsibility for overseeing clinical care and stewardship of resources, Medicaid Medical Directors share their perspectives on clinical matters related to the FDA’s Accelerated Approval Program.

Leveraging data from AcademyHealth’s Medicaid Outcomes Distributed Research Network (MODRN), new research finds substantial improvements in use of medications for OUD. Improved understanding of the factors driving this increase is crucial to closing remaining treatment gaps.